YU41539B - Process for btaining new acetic acid derivatives - Google Patents

Process for btaining new acetic acid derivatives

Info

Publication number
YU41539B
YU41539B YU598/83A YU59883A YU41539B YU 41539 B YU41539 B YU 41539B YU 598/83 A YU598/83 A YU 598/83A YU 59883 A YU59883 A YU 59883A YU 41539 B YU41539 B YU 41539B
Authority
YU
Yugoslavia
Prior art keywords
acid
propyl
acetic acid
june
represent
Prior art date
Application number
YU598/83A
Other versions
YU59883A (en
Inventor
G M Tillandier
J L A Benoit-Guyod
M Broll
A L Boucherle
P L Eymard
B Ferrandes
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of YU59883A publication Critical patent/YU59883A/en
Publication of YU41539B publication Critical patent/YU41539B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/095—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of esters of organic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/60—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by elimination of -OH groups, e.g. by dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.
YU598/83A 1974-06-26 1983-03-11 Process for btaining new acetic acid derivatives YU41539B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28416/74A GB1485269A (en) 1974-06-26 1974-06-26 Pharmaceutical compositions containing acetic acid derivatives

Publications (2)

Publication Number Publication Date
YU59883A YU59883A (en) 1983-12-31
YU41539B true YU41539B (en) 1987-08-31

Family

ID=10275286

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1629/75A YU40439B (en) 1974-06-26 1975-06-25 Process for obtaining acetic acid derivatives
YU598/83A YU41539B (en) 1974-06-26 1983-03-11 Process for btaining new acetic acid derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU1629/75A YU40439B (en) 1974-06-26 1975-06-25 Process for obtaining acetic acid derivatives

Country Status (21)

Country Link
JP (1) JPS6041058B2 (en)
AR (2) AR205748A1 (en)
AT (1) AT341490B (en)
CA (1) CA1041015A (en)
CH (2) CH609668A5 (en)
DE (1) DE2528025A1 (en)
DK (1) DK288775A (en)
ES (1) ES438905A1 (en)
FI (1) FI66834C (en)
FR (1) FR2276036A1 (en)
GB (1) GB1485269A (en)
HU (1) HU174772B (en)
IE (1) IE42947B1 (en)
IT (1) IT1049449B (en)
NL (1) NL7507253A (en)
NO (1) NO146905C (en)
NZ (1) NZ177837A (en)
OA (1) OA05039A (en)
SE (2) SE427926B (en)
YU (2) YU40439B (en)
ZA (1) ZA753800B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558154B1 (en) * 1984-01-16 1986-08-29 Pf Medicament C10 TO C20 BRANCHED FATTY ACIDS USEFUL AS MEDICAMENTS, AND PROCESS FOR THEIR PREPARATION
GB2323706B (en) * 1997-03-13 2002-02-13 United Microelectronics Corp Method to inhibit the formation of ion implantation induced edge defects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484486A (en) * 1946-05-15 1949-10-11 Eastman Kodak Co Preparation of carboxylic acids by the reduction of beta lactones
US2484500A (en) * 1947-10-28 1949-10-11 Eastman Kodak Co Preparation of propionic acids by reduction of beta propiono lactones
FR2442M (en) * 1962-10-17 1964-04-06 Henry Eugene Dipropylacetic acid and its derivatives as new central nervous system depressants.

Also Published As

Publication number Publication date
AT341490B (en) 1978-02-10
NO752270L (en) 1975-12-30
NO146905B (en) 1982-09-20
SE427926B (en) 1983-05-24
FR2276036A1 (en) 1976-01-23
SE7907843L (en) 1979-09-21
FI66834C (en) 1984-12-10
HU174772B (en) 1980-03-28
AU8239375A (en) 1977-01-06
CH609667A5 (en) 1979-03-15
CH609668A5 (en) 1979-03-15
ES438905A1 (en) 1977-02-01
ZA753800B (en) 1976-05-26
IE42947L (en) 1975-12-26
FR2276036B1 (en) 1978-11-10
AR205748A1 (en) 1976-05-31
IT1049449B (en) 1981-01-20
NL7507253A (en) 1975-12-30
FI751888A (en) 1975-12-27
NO146905C (en) 1982-12-29
CA1041015A (en) 1978-10-24
YU40439B (en) 1986-02-28
FI66834B (en) 1984-08-31
JPS5129216A (en) 1976-03-12
IE42947B1 (en) 1980-11-19
DK288775A (en) 1975-12-27
YU162975A (en) 1983-09-30
DE2528025A1 (en) 1976-01-15
SE435275B (en) 1984-09-17
YU59883A (en) 1983-12-31
GB1485269A (en) 1977-09-08
JPS6041058B2 (en) 1985-09-13
AR212236A1 (en) 1978-06-15
OA05039A (en) 1980-12-31
SE7507297L (en) 1975-12-29
ATA487575A (en) 1977-06-15
NZ177837A (en) 1978-12-18

Similar Documents

Publication Publication Date Title
IE45256L (en) Quinazolone derivatives
AU6791781A (en) Piperazino phenylindane
ES482787A1 (en) Flavans, process for their preparation and pharmaceutical compositions containing them.
HUP0003577A2 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
DE3676179D1 (en) N-CONTAINING HETEROCYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME.
GB1285400A (en) Esters of substituted anthranilic acid
ZA839615B (en) Dialkyl-amino-alkoxy derivatives,process for their preparation and pharmaceutical compositions containing them
YU41539B (en) Process for btaining new acetic acid derivatives
GB859546A (en) Composition for treatment of the skin
ES8308833A1 (en) Novel 3-phenyl-1-indanamines, pharmaceutical compositions and methods of preparation.
ATE1442T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ALL-E- OR 13-Z-7,8-DEHYDRO-RETINOIC ACID AND PROCESS FOR ITS PREPARATION.
DE61397T1 (en) SOLUBLE, N2-SUBSTITUTED DERIVATIVES OF 2,4-DIAMINO-5-BENZYL-PYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM.
ES424274A1 (en) 4-Alkyldioxyalkylene-5-benzylpyrimidines
ATE66920T1 (en) NEW CARBONIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND MEDICATIONS CONTAINING THESE COMPOUNDS.
IL51065A (en) Pharmaceutical compositions containing triphenylmethanedi-carboxylic acid derivatives and analogs thereof,some novel compounds of this type and process for their preparation
GB849755A (en) Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones
ATE30712T1 (en) 4-HYDROXY-ALPHA-AETHYL-BENZHYDROLS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
ATE26271T1 (en) BENZHYDRYLPIPERAZINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2373528A1 (en) NEW DERIVATIVES OF 1-AZIRIDINO-CARBOXYLIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS IMMUNO-STIMULANT MEDICINAL PRODUCTS
GB1333565A (en) Therapeutic compositions
ES424362A1 (en) Method of stabilizing a topical ophthalmic formulation
GB1268747A (en) Novel 2-naphthyl-2-hydroxy-acetamidine derivatives, their preparation and use
FR2224152A1 (en) Thiazolotriazolyl phosphorothioates as anthelmintics - combining good anthelmintic activity with low toxicity to warm-blooded animals
GB1012619A (en) Improvements in or relating to dibenzocyclohepta-diene and -triene derivatives
ATE24712T1 (en) 1,3-BIS(DIMETHYLAMINO)-2-PROPYL-4CHLORPHENOXYACETATE, ITS ACID ADDITION SALTS, PROCESS FOR ITS PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.